ORIGINAL RESEARCH

Plasma low molecular weight aminothiols in ischemic stroke patients with type 2 diabetes mellitus

Maksimova MYu1, Ivanov AV2, Nikiforova KA2, Virus ED2, Suanova ET3, Ochtova FR3, Piradov MA1, Kubatiev AA2
About authors

1 Research Center of Neurology, Moscow, Russia

2 Research Institute of General Pathology and Pathophysiology, Moscow, Russia

3 Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Correspondence should be addressed: Marina Yu. Maksimova
Volokolamskoe shosse, 80, Moscow, 125367, Russia; ur.liam@avomixamncn

About paper

Author contribution: Maksimova МYu — concept formulation, data synthesis, manuscript writing; Ivanov AV — concept formulation, literature analysis, assessment of low molecular weight aminothiols; Nikiforova KA — primary laboratory data acquisition; Virus ED — laboratory data synthesis; Suanova ЕТ — statistical data processing; Ochtova FR — clinical assessment of patients; Piradov MA — study management; Kubatiev AA — study management.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Center of Neurology (protocol № 3-1/16 dated March 16, 2016), it was carried out in accordance with the basic principles outlined in the Declaration of Helsinki.

Received: 2021-10-25 Accepted: 2021-11-13 Published online: 2021-12-09
|

It was found that ischemic stroke (IS) results in decreased levels of a number of reduced forms of low molecular weight aminothiols (LMWTs). The study was aimed to assess the impact of type 2 diabetes mellitus (Т2D) on the total content, reduced forms and redox status of LMWTs in patients with IS. A total of 175 patients with IS in the internal carotid artery basin (the average age was 62 (55–69)) years) were assessed, who were admitted to the Center within the first 10–24 h since the onset of neurological disorder. The index group included 68 patients with IS and T2D (males made up 41.2%). The comparison group consisted of 107 patients with IS and stress hyperglycemia (males made up 57%), and the control group included 31 non-diabetic patients with chronic cerebrovascular disease (CCVD) (males made up 54.8%). The admission plasma levels of LMWTs were assessed by liquid chromatography in all patients. It was found, that IS in patients with T2D was associated with the rapid decrease in total cysteine (tCys), total glutathione (tGSH), total homocysteine (tHcy), reduced glutathione (rGSH), and glutathione redox status (GSH RS), along with the increase in cysteine redox status (Cys RS) and homocysteine redox status (Hcy RS). In contrast to patients with stress hyperglycemia developing during the acute period of IS, patients with T2D had lower tCys, tGSH, and tHcy levels. Thus, GSH RS of 4.06% or lower in the first 24 hours after the IS in patients with T2D was a predictor of poor functional outcome (mRS score was 3 or more 3 weeks after IS).

Keywords: ischemic stroke, type 2 diabetes mellitus, low molecular weight aminothiols

КОММЕНТАРИИ (0)